Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants-Reference-Cited by-同舟云学术

Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants

Published:2023-01 Issue:1 Volume:42 Page:111995
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Meyer Saskia,Blaas Isaac,Bollineni Ravi Chand^ORCID,Delic-Sarac Marina,Tran Trung T.,Knetter Cathrine,Dai Ke-Zheng,Madssen Torfinn Støve,Vaage John T.,Gustavsen Alice,Yang Weiwen,Nissen-Meyer Lise Sofie Haug,Douvlataniotis Karolos,Laos Maarja,Nielsen Morten Milek,Thiede Bernd,Søraas Arne,Lund-Johansen Fridtjof,Rustad Even H.,Olweus Johanna

Funder

Research Council of Norway

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference79 articles.

1. T cell immunity to COVID-19 vaccines;Wherry;Science,2022

2. Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy;Sormani;EBioMedicine,2022

3. T cell responses to SARS-CoV-2 spike cross-recognize Omicron;Keeton;Nature,2022

4. The Third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variants;Chen;Emerg. Microbes Infect.,2022

5. Emergence of immune escape at dominant SARS-CoV-2 killer T cell epitope;Dolton;Cell,2022

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic surveillance and vaccine response to the dominant SARS-CoV-2 XBB lineage in Rio Grande do Sul;Scientific Reports;2024-07-22

2. Quantification of heterogeneity in human CD8⁺T cell responses to vaccine antigens: an HLA-guided perspective;2024-07-03

3. SARS-CoV-2-specific T cell responses: a comparative analysis between QuantiFERON SARS-CoV-2, T-SPOT.COVID, and an in-house Omicron ELISpot;Journal of Virological Methods;2024-06

4. Newcastle disease virus vector-based SARS-CoV-2 vaccine candidate AVX/COVID-12 activates T cells and is recognized by antibodies from COVID-19 patients and vaccinated individuals;Frontiers in Immunology;2024-05-30

5. Long-term humoral and cellular immunity against vaccine strains and Omicron subvariants (BQ.1.1, BN.1, XBB.1, and EG.5) after bivalent COVID-19 vaccination;Frontiers in Immunology;2024-05-02